Search results
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 5 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...
Benzinga· 5 days agoOn Friday, Pfizer Inc PFE released longer-term follow-up results from the Phase 3 CROWN trial...
Alphabet, Ventas, ASML And A Pharmaceutical Giant On CNBC’s ‘Final Trades’ - Alphabet (NASDAQ:GOOGL)
Benzinga· 8 hours agoAlphabet recently declared a $2 billion investment plan to establish its inaugural data center and...
7 Overlooked Stocks That Belong in Every Portfolio
InvestorPlace· 2 days agoOverlooked stocks are not necessarily underperforming the market. In some cases, these stocks simply are slow and steady at a time when investors want to...
Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line
InvestorPlace· 2 days agoAs you approach retirement, it’s crucial to carefully consider your investment portfolio and make...
3 Dividend Stocks You May Want To Double Down On
Benzinga via Yahoo Finance· 1 day agoSometimes, misunderstood stocks benefit investors. Savvy investors can capitalize when a stock is incorrectly perceived as weak during a recession....
NVIDIA is a shoo-in for the Dow post stock split By Investing.com
Investing.com· 5 days agoThe split, which will be distributed at the close on June 7th, will give shareholders ten shares in...
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
Motley Fool via Yahoo Finance· 2 days agoAT&T AT&T slashed its dividend payout in 2022 to compensate for the spinoff of its media assets. The...
The Dow Dumped Exxon in 2020. Adding Salesforce Was a Losing Move.
Barrons.com· 5 days agoThe call, meant to make the benchmark better represent the economy, has left investors tracking the...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks via Yahoo Finance· 2 days agoGSK shares decline more than 7% in pre-market trading on Monday in response to an unfavorable ruling...